MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?
oleh: A. Gomez-Iturriaga, D. Büchser, I. San Miguel, M. Marban, A. Urresola, A. Ezquerro, A. Gil, F. Suarez, A. Gonzalez, E. Mairata, L. Martinez-Indart, J. Cacicedo, F. Couñago, P. Mínguez, F. Casquero
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2020-09-01 |
Deskripsi
MRI-detected T3a prostate cancer is a heterogeneous disease. This post-hoc analysis of a prospective trial found that patients with T3a disease presenting obliteration of the recto-prostatic angle, contact-asymmetry of neuro-vascular bundle and periprostatic fat invasion, may be at higher risk of biochemical failure and metastases.